Models of Hepatocellular Carcinoma and Biomarker Strategy

Cancers - Switzerland
doi 10.3390/cancers2031441
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

DNA Methylation: Potential Biomarker in Hepatocellular Carcinoma

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2014English

Solitary Large Hepatocellular Carcinoma: Staging and Treatment Strategy

PLoS ONE
Multidisciplinary
2016English

Oncogenic Wnt3a: A Promising Specific Biomarker in Hepatocellular Carcinoma

Hepatoma Research
2018English

Straightforward and Highly Efficient Strategy for Hepatocellular Carcinoma Glycoprotein Biomarker Discovery Using a Nonglycopeptide-Based Mass Spectrometry Pipeline

English

A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy

Cancers
Cancer ResearchOncology
2020English

Identification of CELSR2 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Histamine Is a Helpful Novel Serological Biomarker for Experimental Hepatocellular Carcinoma

Bulletin of Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2016English

Identification and Validation of Alternative Splicing Isoforms as Novel Biomarker Candidates in Hepatocellular Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2018English

Provocative Gene Therapy Strategy for the Treatment of Hepatocellular Carcinoma

Hepatology
MedicineHepatology
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy